An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis

Published:2014-05-28 Issue:8 Volume:54 Page:901-909
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Wilson Jo-Anne S.¹²,Goralski Kerry B.¹³,Soroka Steven D.²,Morrison Matthew¹,Mossop Paula²,Sleno Lekha⁴,Wang Yan¹,Anderson David R.⁵

Affiliation:

1. College of Pharmacy, Faculty of Health Professions; Dalhousie University; Halifax Nova Scotia Canada

2. Division of Nephrology; Department of Medicine; Capital District Health Authority; Halifax Nova Scotia Canada

3. Department of Pharmacology; Faculty of Medicine; Dalhousie University; Halifax Nova Scotia Canada

4. Department of Chemistry/Pharmaqam; Université du Québec à Montréal; Montreal Quebec Canada

5. Division of Hematology; Department of Medicine; Capital District health Authority; Halifax Nova Scotia Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Frequency of atrial fibrillation and factors related to its development in dialysis patients;Atar;Int J Cardiol,2006

2. Chronic renal insufficiency Cohort (CRIC) Study Group. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC);Soiman;Am Heart J,2010

3. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency;Das;Cardiol Rev,2006

4. Dilemmas in the management of atrial fibrillation in chronic kidney disease;Reinecke;J Am Soc Nephrol,2009

5. Influence of atrial fibrillation on the morbidity and mortality of patients on hemodialysis;Vazquez;Am Heart J,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of direct oral anticoagulants in patients on chronic hemodialysis: Contemporary appraisal on the role for patients with atrial fibrillation;Trends in Cardiovascular Medicine;2023-12

2. Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies;International Journal of Molecular Sciences;2023-03-03

3. Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2023-02-07

4. A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease;Annals of Pharmacotherapy;2021-08-29

5. Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report;Thrombosis Journal;2021-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3